Bottom line
JAFKX vs PRHSX: the short answer
JAFKX (Health Sciences Trust) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds.
PRHSX is cheaper at 0.83% vs 1.24% — a difference of $41 a year per $10,000 invested.
Over five years, PRHSX returned +4.2% a year vs +3.9% for JAFKX.
Updated Nov 19, 2026
JAFKX vs PRHSX side by side
| JAFKX | PRHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | John Hancock | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.24% | 0.83% |
| Annual cost per $10k | $124 | $83 |
| 10-yr cost on $10k (prospectus) | $1,510 | $1,025 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +19.2% | +17.7% |
| 5-yr return (annualized) | +3.9% | +4.2% |
| 10-yr return (annualized) | +8.5% | +9.1% |
| Best quarter | — | +23.5% |
| Worst quarter | — | −15.8% |
| Net assets (fund) | $251.3M | $11.9B |
| Number of holdings | 173 | 279 |
| Portfolio turnover | 68% | 62% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
24 of JAFKX's top 25 holdings also appear in PRHSX's top 25.
| Holding | JAFKX | PRHSX |
|---|---|---|
| Eli Lilly and Company | 14.30% | 14.28% |
| Johnson and Johnson | 6.33% | 6.63% |
| UnitedHealth Group Incorporated | 5.95% | 5.99% |
| AbbVie Inc. | 5.28% | 5.10% |
| Merck and Co. Inc. | 4.21% | 4.01% |
| Gilead Sciences Inc. | 2.95% | 2.82% |
| Thermo Fisher Scientific Inc. | 2.67% | 2.52% |
| Vertex Pharmaceuticals Incorporated | 2.38% | 2.28% |
| Bristol-Myers Squibb Company | 2.22% | 2.11% |
| Abbott Laboratories | 2.00% | 1.89% |
| Intuitive Surgical Inc. | 1.98% | 1.87% |
| Amgen Inc. | 1.90% | 1.82% |
| Stryker Corporation | 1.87% | 1.78% |
| Elevance Health Inc. | 1.63% | 1.53% |
| Danaher Corporation | 1.51% | 1.43% |
Source: SEC Form N-PORT
JAFKX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
FAQ
What is the difference between JAFKX and PRHSX?
JAFKX (Health Sciences Trust) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) are both mutual funds. PRHSX is cheaper at 0.83% vs 1.24% — a difference of $41 a year per $10,000 invested.
Which is cheaper, JAFKX or PRHSX?
PRHSX has the lower expense ratio (0.83%).
Should I own both JAFKX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.